In diagnosing CF, clinicians assess for a clinical presentation consistent with CF, evidence of in vivo CFTR dysfunction based on elevated sweat chloride testing (≥ 60 mmol/L), and two disease-causing CFTR variants [11]. The gene discussed is CFTR; the disease is cystic fibrosis.